Cargando…

The journey of antimalarial drugs against SARS-CoV-2: Review article

The recent outbreak of coronavirus pandemic (COVID-19) introduced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has greatly affected the global public health. This pandemic disease became particularly threatening after the start of a new wave. Vaccines of tested efficacy to stop CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarhan, Amany A., Ashour, Nada A., Al‐Karmalawy, Ahmed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132553/ https://www.ncbi.nlm.nih.gov/pubmed/34028468 http://dx.doi.org/10.1016/j.imu.2021.100604

Ejemplares similares

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
por: Ashour, Nada A, et al.
Publicado: (2022)

Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies
por: Zaki, Ahmed A., et al.
Publicado: (2021)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
por: Mahmoud, Amal, et al.
Publicado: (2021)

From Pandemicity to Endemicity: The Journey of SARS-CoV-2
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Integrated computational approach towards repurposing of antimalarial drug against SARS-CoV-2 main protease
por: Gogoi, Neelutpal, et al.
Publicado: (2022)

Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’
por: Campesi, Ilaria, et al.
Publicado: (2021)

Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro
por: Salas Rojas, Mónica, et al.
Publicado: (2021)

Anticoagulants as Potential SARS-CoV-2 M(pro) Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
por: Abo Elmaaty, Ayman, et al.
Publicado: (2022)

The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review
por: Das, Subham, et al.
Publicado: (2021)

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
por: Antar, Samar A., et al.
Publicado: (2022)

Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
por: Antar, Samar A., et al.
Publicado: (2023)

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
por: Shehata, Mahmoud M., et al.
Publicado: (2021)

RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
por: Zaidi, Asiya Kamber, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Observations on article on healthcare workers & SARS-CoV-2 infection
por: Kulkarni, A.P.
Publicado: (2020)

Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
por: Firestone, Tessa M., et al.
Publicado: (2021)

Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study
por: Elmaaty, Ayman Abo, et al.
Publicado: (2021)

Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors
por: El-Demerdash, Amr, et al.
Publicado: (2021)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences
por: Alshammary, Amal F., et al.
Publicado: (2021)

[Translated article] RF-SARS-CoV-2 Vaccination and Immunotherapy in Dermatology
por: Rodríguez-Villa Lario, A., et al.
Publicado: (2022)

New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2
por: Seliem, Israa A., et al.
Publicado: (2021)

[Translated article] Facial Vitiligo After SARS-CoV-2 Vaccination
por: Flores-Terry, M.Á., et al.
Publicado: (2022)

A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Drosos, Alexandros A., et al.
Publicado: (2022)

The Use of Antimalarial Drugs against Viral Infection
por: D’Alessandro, Sarah, et al.
Publicado: (2020)

Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies
por: Mahmoud, Dina B., et al.
Publicado: (2021)

Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?
por: Hessien, Mohamed, et al.
Publicado: (2023)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

Host gene variability and SARS-CoV-2 infection: A review article
por: Kaidashev, I., et al.
Publicado: (2021)

An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19
por: Calvelo, Martín, et al.
Publicado: (2020)

Pericardial Tamponade following Asymptomatic SARS-CoV-2 Infection: A Diagnostic Journey
por: Birner, Christian, et al.
Publicado: (2022)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets
por: Arooj, Mahreen, et al.
Publicado: (2021)

Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article
por: Azzam, Ahmed Y, et al.
Publicado: (2022)

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines
por: Vitte, Joana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ql95p7quagu4o010ouu8nl7g28